The global rheumatoid arthritis therapeutics market size is
expected to reach USD 30.4 billion by 2025, according to a new report by Grand
View Research, Inc., expanding at a CAGR of 4.6% during the forecast period.
Some of the key trends driving the market are availability of novel biologics,
increase in potential clinical pipeline candidates, and rise in aging
population. Thus, growing availability and awareness of safer drugs are
projected to escalate rheumatoid arthritis drugs market growth.
Rheumatoid arthritis affects
approximately 1% of the global population. The condition has different symptoms
such as joint pain, swelling, and stiffness, which are generally accompanied by
chronic pain and inability to perform daily activities. Over a prolonged
period, this disorder can hamper a patient’s mobility and can lead to permanent
joint damage. If left untreated, this disorder can lead to mobility impairment
and risk of joint replacement.
Growing prevalence of the disease,
presence of biologics & biosimilars, and well-defined regulatory guidelines
are poised to provide a fillip to the market. According to the Arthritis
Foundation, 64% of the population within the age group of 65 is likely to
suffer from arthritis in U.S. Increasing awareness regarding disease remittance
therapies and rising healthcare expenditure in developed regions are estimated
to promote revenue growth.
Current treatment for rheumatoid
arthritis includes generic pharmaceuticals such as NSAIDs and corticosteroids
along with novel biologics such as JAK inhibitors and IL-6 antagonists, which
are widely used in developed countries due to their high effectiveness. New
product launches such as Infliximab and Adalimumab biosimilars are anticipated
to work in favor of the market. Moreover, Eli Lilly’s Olumiant and AbbVie’s
Upadacitinib are expected to cut down chances of disease remittance.
Browse full research report on Rheumatoid Arthritis
Drugs/Therapeutics Market: https://www.grandviewresearch.com/industry-analysis/rheumatoid-arthritis-therapeutics-market
Further key findings from the report suggest:
- North America held 56.6% of the market in 2016 due to rising
awareness regarding disease treatment, growing geriatric population, and
high adoption of biopharmaceuticals for treatment
- Due to growing popularity, the biopharmaceuticals segment is
projected to exhibit a CAGR of 8.3% during the forecast period
- Prescriptions are anticipated to emerge as more reliable and
a preferred sales channel over the same period
- Asia Pacific is the most promising region, registering a CAGR
of 9.5% between 2017 and 2025
- Some of the key players in rheumatoid arthritis market are
AbbVie; Boehringer Ingelheim GmbH; Novartis AG; Regeneron Pharmaceuticals,
Inc.; Pfizer, Inc.; Bristol-Myers Squibb Company; F. Hoffmann-La Roche
Ltd.; UCB S.A.; Johnson & Johnson Services, Inc.; and Amgen, Inc.
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/rheumatoid-arthritis-therapeutics-market/request/rs1
Grand View Research has segmented the rheumatoid arthritis
drugs/therapeutics market on the basis of molecule types, sales channels, and
region:
- Pharmaceuticals
- NSAIDs
- Analgesics
- DMARDs
- Glucocorticoids
- Biopharmaceuticals
- Biologics
- TNF-α
antagonists
- T-cell
inhibitors
- CD20
antigen
- JAK
inhibitors
- anti-IL6
biologics
- Biosimilars
- CD20
antigen
- TNF-α
antagonists
Rheumatoid Arthritis Therapeutics Sales Channel Outlook (Revenue,
USD Million, 2014 - 2025)
- Prescription
- Over-the-Counter
(OTC)
Rheumatoid Arthritis Therapeutics Regional Outlook (Revenue, USD
Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Mexico
- Middle
East & Africa
- South
Africa
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For
more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment